Gladiola Tantaru

Gladiola Tantaru

Auto-generated profile, based on publicly available information

Gladiola Tantaru

Department of Analytical Chemistry, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, 16, University Str., 700115 Iasi, Romania

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2002 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
GTGladiola Tantaru
Gladiola Tantaru
VDV Dorneanu
V Dorneanu
MSMaria Stan
Maria Stan

28 November 2019 in International Journal of Polymer Science
Verified
Journal Article
Open access
PDF file
ACAndreea Creteanu
Andreea Creteanu
DPDaniela Pamfil
Daniela Pamfil
CVCornelia Vasile
Cornelia Vasile
GTGladiola Tantaru
Gladiola Tantaru
CGCristina Mihaela Ghiciuc
Cristina Mihaela Ghiciuc
AMAna Maria Macsim
Ana Maria Macsim
The aim of this study was to improve the solubility of amiodarone hydrochloride (AMD) and the drug release using its inclusion complexes with 2-hydroxypropyl-β-cyclodextrin (HP-β-CD). The inclusion complexes were prepared by coprecipitation and freeze-drying. The solubility enhancement of AMD/HP-β-CD inclusion complexes by 4–22 times was evaluated by the phase solubility method. The inclusion complexes were studied both in solution and in solid state by spectroscopic methods, dynamic light scattering (DLS) and zeta potential analysis, SEM, and DSC. The formulations of AMD/HP-β-CD inclusion complexes both as powdered form and as matrix tablets showed superior pharmacokinetic performance in improving loading and release properties in respect of those of the insoluble AMD drug. In vitro kinetic study reveals a complex mechanism of release occurring in three steps: the first one being attributed to a burst effect and the other two to different bonding existing in inclusion complexes. An in vivo test on matrix tablets containing Kollidon® and chitosan also reveals a multiple (at least two) peaks release diagram because of both structures of the inclusion complexes and also of different sites of absorption in biological media (digestive tract).

6 June 2012 in Applied Organometallic Chemistry
Verified
Journal Article
Closed access
PDF file
GTGladiola Tantaru
Gladiola Tantaru
Maria-Cristina PopescuMaria-Cristina Popescu
Maria-Cristina Popescu
VBVeronica Bild
Veronica Bild
APAntonia Poiata
Antonia Poiata
GLGabriela Lisa
Gabriela Lisa
CVCornelia Vasile
Cornelia Vasile

2 February 2014 in Environmental Monitoring and Assessment
Verified
Journal Article
Closed access
PDF file
GTGladiola Tantaru
Gladiola Tantaru
MVMadalina Vieriu
Madalina Vieriu
Maria-Cristina PopescuMaria-Cristina Popescu
Maria-Cristina Popescu

15 May 2017 in Revista de Chimie
Verified
Journal Article
Open access
MAMihai Apostu
Mihai Apostu
GTGladiola Tantaru
Gladiola Tantaru
MVMadalina Vieriu
Madalina Vieriu
APAlina Diana Panainte
Alina Diana Panainte
NBNela Bibire
Nela Bibire
LALuminita Agoroaei
Luminita Agoroaei
Mihai Apostu, Gladiola Tantaru, Madalina Vieriu, Alina Diana Panainte, Nela Bibire, Luminita Agoroaei - Evaluation of in Vitro Reducing Effect of Several Vegetable Extracts on the Digestive Bioavailability of Heavy Metals

15 August 2019 in Revista de Chimie
Verified
Journal Article
Closed access
GTGladiola Tantaru
Gladiola Tantaru
MAMihai Apostu
Mihai Apostu
APAntonia Poiata
Antonia Poiata
MNMihai Nichifor
Mihai Nichifor
NBNela Bibire
Nela Bibire
MVMadalina Vieriu
Madalina Vieriu
The paper presents the synthesis of a new complex combination of a Bis-Schiff base with Mn(II) ions with great potential for antimicrobial and anti-inflammatory activity. A new complex of the Salen-type ligand, 1-ethyl-salicylidene-bis-ethylene diamine was synthetized using Mn(II) ions. The chemical structure was confirmed through 1H-NMR and IR spectroscopy. The antimicrobial activities of the Bis-Schiff base and its complex were tested in comparison with Ampicillin, Chloramphenicol, Tetracycline, Ofloxacin and Nystatin. Those compounds were found to be active against Gram-positive or Gram-negative bacteria, and had an anti-inflammatory effect comparable to that of Indomethacin.